marzan, thanks for the post. One thing. You wrote :
Whereas in our trial, we have about 15% of the trial patients survive thru 5yrs while only about 6% survive 5yrs in the standard care which is more than 200% improvement.
The improvement is from 6% to 15% overall survival. This is a difference of 9, which means an improvement of 150% on the original 6%. So still very good and maybe even better at this moment.